HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in stem cell transplants for blood cancer patients
Disease control CompletedThis study tested a new form of the drug melphalan (EVOMELA) combined with other treatments before a stem cell transplant from a half-matched donor. It included 43 adults with blood cancers like multiple myeloma. The goal was to see if the treatment was safe and helped patients l…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
Immune booster: donor NK cells show promise in blood cancer transplant safety trial
Disease control CompletedThis early-phase study tested whether giving specially selected donor immune cells (called NK cells) after a stem cell transplant is safe for people with blood cancers. Seventeen patients received the cells, and researchers monitored for serious side effects within 30 days. The g…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated May 19, 2026 11:47 UTC